Uzpruvo

Biosimilar medicine authorized by the AEMPS

Uzpruvo®

ACTIVE PRINCIPLE:
Believable

INDICATION:
plaque psoriasis
Psoriasic arthritis
Crohn's disease
Ulcerative colitis

DATE:
11/01/2024

STATUS:
Authorized

MORE INFORMATION

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE